Genetic evidence for an interferon-antagonistic function of Rift Valley fever virus nonstructural protein NSs

被引:302
作者
Bouloy, M
Janzen, C
Vialat, P
Khun, H
Pavlovic, J
Huerre, M
Haller, O [1 ]
机构
[1] Univ Freiburg, Inst Med Mikrobiol & Hyg, Abt Virol, D-79008 Freiburg, Germany
[2] Inst Pasteur, Grp Bunyavirides, F-75724 Paris, France
[3] Inst Pasteur, Histopathol Unit, F-75724 Paris, France
[4] Univ Zurich, Inst Med Virol, CH-8028 Zurich, Switzerland
关键词
D O I
10.1128/JVI.75.3.1371-1377.2001
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Rift Valley fever vints (RVFV), a phlebovirus of the family Bunyaviridae, is a major public health threat in Egypt and sub-Saharan Africa. The viral and host cellular factors that contribute to RVFV virulence and pathogenicity are still poorly understood. All pathogenic RVFV strains direct the synthesis of a nonstructural phosphoprotein (NSs) that is encoded by the smallest (S) segment of the tripartite genome and has an undefined accessory function. In this report, we show that MP12 and clone 13, two attenuated RVFV strains with mutations in the NSs gene, were highly virulent in IFNAR(-/-) mice lacking the alpha/beta interferon (IFN-alpha/beta) receptor but remained attenuated in IFN-gamma receptor-deficient mice. Both attenuated strains proved to be excellent inducers of early IFN-alpha/beta production. In contrast, the virulent strain ZH548 failed to induce detectable amounts of IFN-alpha/beta and replicated extensively in both IFN-competent and IFN-deficient mice. Clone 13 has a defective NSs gene with a large in-frame deletion. This defect in the NSs gene results in expression of a truncated protein which is rapidly degraded. To investigate whether the presence of the wild-type NSs gene correlated with inhibition of IFN-alpha/beta production, we infected susceptible IFNAR(-/-) mice with S gene reassortant viruses. When the S segment of ZH548 was replaced by that of clone 13, the resulting reassortants became strong IFN inducers, When the defective S segment of clone 13 was exchanged with the wild-type S segment of ZH548, the reassortant virus lost the capacity to stimulate IFN-alpha/beta production. These results demonstrate that the ability of RVFV to inhibit IFN-alpha/beta production correlates with viral virulence and suggest that the accessory protein NSs is an IFN antagonist.
引用
收藏
页码:1371 / 1377
页数:7
相关论文
共 47 条
[31]   FUNCTIONAL-ROLE OF TYPE-I AND TYPE-II INTERFERONS IN ANTIVIRAL DEFENSE [J].
MULLER, U ;
STEINHOFF, U ;
REIS, LFL ;
HEMMI, S ;
PAVLOVIC, J ;
ZINKERNAGEL, RM ;
AGUET, M .
SCIENCE, 1994, 264 (5167) :1918-1921
[32]   INSITU ANALYSIS OF PROTEOLIPID PROTEIN GENE TRANSCRIPTS DURING PERSISTENT THEILERS VIRUS-INFECTION [J].
OZDEN, S ;
AUBERT, C ;
GONZALEZDUNIA, D ;
BRAHIC, M .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1991, 39 (10) :1305-1309
[33]  
Peters C. J., 1981, Rift Valley fever. Proceedings of a Workshop on Rift Valley fever, Herzlia, Israel, March 18-21, 1980., P21
[34]   PROPHYLAXIS OF RIFT-VALLEY FEVER WITH ANTIVIRAL DRUGS, IMMUNE SERUM, AN INTERFERON INDUCER, AND A MACROPHAGE ACTIVATOR [J].
PETERS, CJ ;
REYNOLDS, JA ;
SLONE, TW ;
JONES, DE ;
STEPHEN, EL .
ANTIVIRAL RESEARCH, 1986, 6 (05) :285-297
[35]   An I kappa B homolog encoded by African swine fever virus provides a novel mechanism for downregulation of proinflammatory cytokine responses in host macrophages [J].
Powell, PP ;
Dixon, LK ;
Parkhouse, RME .
JOURNAL OF VIROLOGY, 1996, 70 (12) :8527-8533
[36]   Analysis of the 3' terminal sequence recognized by the Rift Valley fever virus transcription complex in its ambisense S segment [J].
Prehaud, C ;
Lopez, N ;
Blok, MJ ;
Obry, V ;
Bouloy, M .
VIROLOGY, 1997, 227 (01) :189-197
[37]   Inhibition of nuclear factor κB activation by a virus-encoded IκB-like protein [J].
Revilla, Y ;
Callejo, M ;
Rodríguez, JM ;
Culebras, E ;
Nogal, ML ;
Salas, ML ;
Viñuela, E ;
Fresno, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (09) :5405-5411
[38]   Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity [J].
Ronco, LV ;
Karpova, AY ;
Vidal, M ;
Howley, PM .
GENES & DEVELOPMENT, 1998, 12 (13) :2061-2072
[39]   USE OF REASSORTANT VIRUSES TO MAP ATTENUATING AND TEMPERATURE-SENSITIVE MUTATIONS OF THE RIFT-VALLEY FEVER VIRUS MP-12 VACCINE [J].
SALUZZO, JF ;
SMITH, JF .
VACCINE, 1990, 8 (04) :369-375
[40]  
Schmaljohn CS, 1996, FIELDS VIROLOGY, P1447